Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
about
High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionIntra-islet endothelial cell and β-cell crosstalk: Implication for islet cell transplantation.Dynamic, heterogeneous endothelial Tie2 expression and capillary blood flow during microvascular remodelingRole of Angiopoietins and Tie-2 in Diabetic Retinopathy.
P2860
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
@en
type
label
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
@en
prefLabel
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
@en
P2860
P1476
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
@en
P2093
Kevin G Peters
Peter A Campochiaro
P2860
P2888
P356
10.1007/S11892-016-0816-5
P577
2016-12-01T00:00:00Z
P6179
1020386461